Schizophrenia Research

Aims & Scope

As official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community.

More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!

Schizophrenia Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.

The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	3.60

SJR (SCImago Journal Rank)

Year	Value
2024	1.213

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	204

Journal Rank

Year	Value
2024	3497

Journal Citation Indicator

Year	Value
2024	2997

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A review of MRI findings in schizophrenia

  Citation: 1819

  Authors: Martha E., Chandlee C., Melissa, Robert W.

• The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

  Citation: 1255

  Authors: R

• Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS

  Citation: 1114

  Authors: Michael F., Robert S., Robert K.

• What does the PANSS mean?

  Citation: 1063

  Authors: S, J, W, J, E, R

• A depression rating scale for schizophrenics

  Citation: 1046

  Authors: Donald, Jean, Bernard

• A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

  Citation: 1024

  Authors: Jose, Francisco J.

• Identification of separable cognitive factors in schizophrenia

  Citation: 1016

  Authors: Keith H., Deanna M., James M., Terry E., Michael F., Robert K.

• Schizophrenia, symptomatology and social inference: Investigating “theory of mind” in people with schizophrenia

  Citation: 934

  Authors: Rhiannon, Gavin, Christopher D.

• Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group

  Citation: 894

  Authors: Alison R, Lisa J, Hok Pan, Shona M, Colleen A, Mats, Patrick D

• Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

  Citation: 886

  Authors: Joseph P., Jonathan M., Donald C., Henry A., Sonia M., Lisa, Herbert Y., John, T., Jeffrey A.

---